Individualized Angiotensin‐Converting Enzyme (ACE)‐Inhibitor Therapy in Stable Coronary Artery Disease Based on Clinical and Pharmacogenetic Determinants: The PERindopril GENEtic (PERGENE) Risk Model

Ace Inhibitor ◽

Risk Model ◽

Inhibitor Therapy ◽

Converting Enzyme ◽

Circadian activity of the endogenous fibrinolytic system in stable coronary artery disease: effects of beta-adrenoreceptor blockers and angiotensin-converting enzyme inhibitors

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(98)00481-1 ◽

1998 ◽

Vol 32 (7) ◽

pp. 1962-1968 ◽

Cited By ~ 24

Author(s):

Jeremy W Sayer ◽

Charles Gutteridge ◽

Denise Syndercombe-Court ◽

Paul Wilkinson ◽

Adam D Timmis

Keyword(s):

Coronary Artery Disease ◽

Coronary Artery ◽

Enzyme Inhibitors ◽

Angiotensin Converting Enzyme Inhibitors ◽

Converting Enzyme ◽

Circadian Activity ◽

Converting Enzyme Inhibitors ◽

Angiotensin-converting enzyme inhibitor therapy in patients non-obstructive coronary artery disease

European Heart Journal ◽

10.1093/eurheartj/eht308.p2278 ◽

2013 ◽

Vol 34 (suppl 1) ◽

pp. P2278-P2278 ◽

Cited By ~ 1

Author(s):

E. Cenko ◽

O. Manfrini ◽

C. Morell ◽

R. Das ◽

J. H. Barth ◽

...

Keyword(s):

Coronary Artery Disease ◽

Coronary Artery ◽

Angiotensin Converting Enzyme Inhibitor ◽

Enzyme Inhibitor ◽

Obstructive Coronary Artery Disease ◽

Inhibitor Therapy ◽

Converting Enzyme ◽

Converting Enzyme Inhibitor ◽

Genetic determinants of treatment benefit of the angiotensin-converting enzyme-inhibitor perindopril in patients with stable coronary artery disease

European Heart Journal ◽

10.1093/eurheartj/ehq169 ◽

2010 ◽

Vol 31 (15) ◽

pp. 1854-1864 ◽

Cited By ~ 55

Author(s):

Jasper Jan Brugts ◽

Aaron Isaacs ◽

Eric Boersma ◽

Cock M. van Duijn ◽

Andre G. Uitterlinden ◽

...

Keyword(s):

Coronary Artery Disease ◽

Coronary Artery ◽

Angiotensin Converting Enzyme Inhibitor ◽

Enzyme Inhibitor ◽

Converting Enzyme ◽

Genetic Determinants ◽

Treatment Benefit ◽

The Rationale and Design of the Perindopril Genetic Association Study (PERGENE): A Pharmacogenetic Analysis of Angiotensin-Converting Enzyme Inhibitor Therapy in Patients with Stable Coronary Artery Disease

Cardiovascular Drugs and Therapy ◽

10.1007/s10557-008-6156-1 ◽

2008 ◽

Vol 23 (2) ◽

pp. 171-181 ◽

Cited By ~ 20

Author(s):

J. J. Brugts ◽

◽

M. P. M. de Maat ◽

E. Boersma ◽

J. C. M. Witteman ◽

...

Keyword(s):

Coronary Artery Disease ◽

Coronary Artery ◽

Association Study ◽

Angiotensin Converting Enzyme Inhibitor ◽

Genetic Association Study ◽

Enzyme Inhibitor ◽

Converting Enzyme ◽

Angiotensin-converting-enzyme inhibition in stable coronary artery disease

ACC Current Journal Review ◽

10.1016/j.accreview.2005.02.062 ◽

2005 ◽

Vol 14 (3) ◽

pp. 11 ◽

Cited By ~ 1

Keyword(s):

Coronary Artery Disease ◽

Coronary Artery ◽

Enzyme Inhibition ◽

Angiotensin Converting Enzyme Inhibition ◽

Converting Enzyme ◽

Converting Enzyme Inhibition ◽

The Cardioprotective Effects of the Angiotensin-Converting Enzyme Inhibitor Perindopril in Patients With Stable Coronary Artery Disease Are Not Modified by Mild to Moderate Renal Insufficiency

Journal of the American College of Cardiology ◽

10.1016/j.jacc.2007.08.029 ◽

2007 ◽

Vol 50 (22) ◽

pp. 2148-2155 ◽

Cited By ~ 33

Author(s):

Jasper J. Brugts ◽

Eric Boersma ◽

Michel Chonchol ◽

Jaap W. Deckers ◽

Michel Bertrand ◽

...

Keyword(s):

Coronary Artery Disease ◽

Coronary Artery ◽

Renal Insufficiency ◽

Enzyme Inhibitor ◽

Converting Enzyme ◽

Cardioprotective Effects ◽

Artery Disease ◽

Moderate Renal Insufficiency

Combination of Isosorbide Dinitrate and Hydralazine in Blacks With Heart Failure. Angiotensin-Converting Enzyme Inhibition in Stable Coronary Artery Disease (PEACE Trial)

Congestive Heart Failure ◽

10.1111/j.1527-5299.2005.04167.x ◽

2005 ◽

Vol 11 (2) ◽

pp. 96-98

Author(s):

Imran Saleem Virk ◽

Randy Ip

Keyword(s):

Heart Failure ◽

Coronary Artery Disease ◽

Coronary Artery ◽

Isosorbide Dinitrate ◽

Angiotensin Converting Enzyme Inhibition ◽

Converting Enzyme ◽

Converting Enzyme Inhibition ◽

Angiotensin-Converting–Enzyme Inhibition in Stable Coronary Artery Disease

New England Journal of Medicine ◽

10.1056/nejmoa042739 ◽

2004 ◽

Vol 351 (20) ◽

pp. 2058-2068 ◽

Cited By ~ 749

Keyword(s):

Coronary Artery Disease ◽

Coronary Artery ◽

Enzyme Inhibition ◽

Angiotensin Converting Enzyme Inhibition ◽

Converting Enzyme ◽

Converting Enzyme Inhibition ◽

Individualised therapy of angiotensin converting enzyme (ACE) inhibitors in stable coronary artery disease: overview of the primary results of the PERindopril GENEtic association (PERGENE) study

Netherlands Heart Journal ◽

10.1007/s12471-011-0173-6 ◽

2011 ◽

Vol 20 (1) ◽

pp. 24-32 ◽

Cited By ~ 12

Author(s):

J. J. Brugts ◽

M. P. M. de Maat ◽

A. H. J. Danser ◽

E. Boersma ◽

M. L. Simoons

Keyword(s):

Coronary Artery Disease ◽

Coronary Artery ◽

Genetic Association ◽

Ace Inhibitors ◽

Converting Enzyme ◽

Should patients with stable coronary artery disease be treated with ACE inhibitor therapy?

Nature Clinical Practice Cardiovascular Medicine ◽

10.1038/ncpcardio0123 ◽

2005 ◽

Vol 2 (3) ◽

pp. 124-125 ◽

Cited By ~ 2

Author(s):

Milan Gupta ◽

Eva M Lonn ◽

Subodh Verma

Keyword(s):

Coronary Artery Disease ◽

Coronary Artery ◽

Ace Inhibitor ◽

Inhibitor Therapy ◽